Literature DB >> 4309084

Assay of the antibiotic activity of serum.

W H Traub.   

Abstract

One of the drawbacks of the "tube dilution" method for the assay of antibiotics in human serum has been illustrated by utilizing serum-sensitive and serum-resistant strains of Escherichia coli. In the case of serum-sensitive strains, it was found that fresh serum alone may account for the same degree of inhibition and thus yield minimal inhibitory concentrations identical to those obtained with serum combined with antibiotics, that is, "simulated" serum assay specimens. This fallacy of the method is discussed with regard to those instances in which laboratories were merely to utilize the patient's own coliform organism as the test organism, or with respect to the assay of, for example, polymyxins, in which inadvertently a R(ough) and therefore, serum-sensitive strain of E. coli were to be used as the indicator organism. It is recommended that serum-resistant laboratory strains of Staphylococcus aureus or E. coli of known antibiotic susceptibility be employed as the test organisms proper in order to circumvent the inherent bactericidal activity of serum.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4309084      PMCID: PMC377884          DOI: 10.1128/am.18.1.51-56.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  8 in total

1.  THE SERUM-DILUTION BACTERICIDAL TEST FOR ANTIBIOTIC EFFECTIVENESS.

Authors:  S G DUNLOP
Journal:  Am J Med Technol       Date:  1965 Jan-Feb

2.  Assay of antibacterial activity in serum. A useful guide for complex antimicrobial therapy.

Authors:  E JAWETZ
Journal:  Am J Dis Child       Date:  1962-01

3.  The antibiotic therapy of bacterial endocarditis: therapeutic data on 172 patients seen from 1951 through 1957: additional observations on short-term therapy (two weeks) for penicillin-sensitivie streptococcal endocarditis.

Authors:  J E GERACI
Journal:  Med Clin North Am       Date:  1958-07       Impact factor: 5.456

4.  A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.

Authors:  R J Roantree; L A Rantz
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

5.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

Review 6.  "Complement".

Authors:  L T Rosenberg
Journal:  Annu Rev Microbiol       Date:  1965       Impact factor: 15.500

7.  IN VITRO AND IN VIVO LABORATORY EVALUATION OF CEPHALOGLYCIN AND CEPHALORIDINE.

Authors:  W E WICK; W S BONIECE
Journal:  Appl Microbiol       Date:  1965-03

8.  Antagonism of polymyxin B and kanamycin sulfate by Liquoid (sodium polyanetholsulfonate) in vitro.

Authors:  W H Traub
Journal:  Experientia       Date:  1969-02-15
  8 in total
  6 in total

1.  Neutralization of human serum lysozyme by sodium polyanethol sulfonate but not by sodium amylosulfate.

Authors:  W H Traub; P I Fukushima
Journal:  J Clin Microbiol       Date:  1978-09       Impact factor: 5.948

2.  Neutralization of human serum beta-lysin by sodium polyanetholsulfonate and sodium amylosulfate.

Authors:  W H Traub; P I Fukushima
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

3.  Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens.

Authors:  W H Traub; I Kleber
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

4.  Inactivation of classical and alternative pathway-activated bactericidal activity of human serum by sodium polyanetholsulfonate.

Authors:  W H Traub; I Kleber
Journal:  J Clin Microbiol       Date:  1977-03       Impact factor: 5.948

5.  Bactericidal effects of human sera versus pathogens.

Authors:  D J Flournoy
Journal:  Experientia       Date:  1980-02-15

6.  Studies on neutralization of human serum bactericidal activity by sodium amylosulfate.

Authors:  W H Traub
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.